Lacuna Pharma specialises in niche and boutique molecules where specialised attention is required for the success of the product by utilising existing KOL networks, MSL engagement, medical education and patient group involvement.

Lacuna Pharma has partnered with experts to manage the tricky regulatory environments across Asia Pacific and complex reimbursement applications. Our partners have an extensive list of regulatory and reimbursement achievements across our territories.

Lacuna Pharma tailor-makes strategies for the Asia Pacific territories working closely with our partners to achieve the best possible outcome for the patients, products and partners.

Lacuna Pharma can commercialise products in Australia, New Zealand, Singapore, Hong Kong, South Korea and other select territories via own capability or partner’s network.